Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

155.46
+2.801.83%
Post-market: 155.460.00000.00%19:47 EDT
Volume:987.64K
Turnover:153.31M
Market Cap:7.65B
PE:-53.38
High:158.76
Open:155.62
Low:153.05
Close:152.66
52wk High:228.88
52wk Low:91.86
Shares:49.22M
Float Shares:48.62M
Volume Ratio:1.00
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9122
EPS(LYR):-2.9122
ROE:-4.23%
ROA:4.24%
PB:2.42
PE(LYR):-53.38

Loading ...

Charles River: SEC concluded inquiry into company, not recommeding enforcement

TIPRANKS
·
Nov 17, 2025

SEC Ends Probe Into Charles River Laboratories With No Enforcement Action

Reuters
·
Nov 17, 2025

Charles River Laboratories-Investigation Was About Inquiry Requesting to Give Information Related to Sourcing Non-Human Primates & Related Disclosures

THOMSON REUTERS
·
Nov 17, 2025

Charles River Laboratories International Inc - SEC Concludes Investigation, No Action Against Charles River Labs - SEC Filing

THOMSON REUTERS
·
Nov 17, 2025

Charles River Laboratories Presents at Jefferies Global Healthcare Conference

Reuters
·
Nov 17, 2025

Charles River Laboratories International Inc : Argus Research Raises to Buy From Hold

THOMSON REUTERS
·
Nov 17, 2025

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Nov 14, 2025

Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

GlobeNewswire
·
Nov 13, 2025

Applied Therapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 13, 2025

Did Lower Guidance and Weak Earnings Just Shift Charles River Laboratories' (CRL) Investment Narrative?

Simply Wall St.
·
Nov 13, 2025

Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

GlobeNewswire
·
Nov 12, 2025

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 12, 2025

Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Nov 12, 2025

Morgan Stanley Adjusts Charles River Laboratories International PT to $185 From $170, Maintains Equal Weight Rating

MT Newswires Live
·
Nov 11, 2025

TD Cowen Adjusts Price Target on Charles River Laboratories International to $197 From $205

MT Newswires Live
·
Nov 10, 2025

U.S. RESEARCH ROUNDUP-DoorDash, Honeywell, Zscaler

Reuters
·
Nov 10, 2025

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 07, 2025

Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Charles River Labs (CRL) and Neumora Therapeutics, Inc. (NMRA)

TIPRANKS
·
Nov 07, 2025

Evercore ISI Sticks to Its Buy Rating for Charles River Labs (CRL)

TIPRANKS
·
Nov 06, 2025

This Charles River Laboratories Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Benzinga_recent_news
·
Nov 06, 2025